VIGL Vigil Neuroscience, Inc.
Biotechnology NasdaqGS
Trading Signals (VIGL)
Overall Signal
BUY
Strong buyish signal based on multiple indicators.
Key Price Levels
Support Levels
- Strong Support $7.98
- Medium Support $8.01
- Weak Support $8.03
Resistance Levels
- Weak Resistance $8.07
- Medium Resistance $8.09
- Strong Resistance $8.12
Stop Loss Suggestions
- Conservative $8.02
- Moderate $8.02
- Aggressive $8
Analyst Ratings
Current Rating
Signal Indicator
| Indicator | Signal | Strength | Timeframe |
|---|---|---|---|
| Moving Averages | NEUTRAL |
|
Short & Medium Term |
| Oscillators | SELL |
|
Short Term |
| Trend Indicators | BUY |
|
Medium Term |
| Volume Indicators | NEUTRAL |
|
Short & Medium Term |
| Support/Resistance | NEUTRAL |
|
Short Term |
Stock Price Prediction Price Target Probabilities (VIGL)
Quarterly Outlook :
2026-11-04
Bullish Scenario
from current 8.45%
Strong upward momentum and confirmed bullish trend, with potential for significant price appreciation. Indicators point to sustained buying pressure. ADX (52.63) indicates a strong trend. +DI > -DI suggests strong bullish directional bias. RSI (80.33) is in the overbought zone, suggesting potential for price correction. MACD line (1.32) is below Signal line (1.33) (bearish crossover), confirming downward momentum. Current Weekly ATR is 0.34, indicating the average weekly price range.
2026-11-04
Base Scenario
from current 0%
Price is likely to continue its moderate trajectory, reflecting underlying market conditions and historical volatility. Indicators suggest a balanced outlook. ADX (52.63) indicates a strong trend. +DI > -DI suggests strong bullish directional bias. RSI (80.33) is in the overbought zone, suggesting potential for price correction. MACD line (1.32) is below Signal line (1.33) (bearish crossover), confirming downward momentum. Current Weekly ATR is 0.34, indicating the average weekly price range.
2026-11-04
Bearish Scenario
from current -8.45%
Increased selling pressure and potential for a significant price correction or downtrend. Indicators suggest waning bullish momentum or strengthening bearish forces. ADX (52.63) indicates a strong trend. +DI > -DI suggests strong bullish directional bias. RSI (80.33) is in the overbought zone, suggesting potential for price correction. MACD line (1.32) is below Signal line (1.33) (bearish crossover), confirming downward momentum. Current Weekly ATR is 0.34, indicating the average weekly price range.
Annual Outlook
2026-11-04
Bullish Scenario
from current 16.89%
Long-term bullish trend with strong fundamental catalysts and sustained institutional buying. Expect significant capital appreciation over the year. ADX (52.63) indicates a strong trend. +DI > -DI suggests strong bullish directional bias. RSI (80.33) is in the overbought zone, suggesting potential for price correction. MACD line (1.32) is below Signal line (1.33) (bearish crossover), confirming downward momentum. Current Weekly ATR is 0.34, indicating the average weekly price range.
2026-11-04
Base Scenario
from current 0%
Steady long-term growth consistent with market and industry averages. Price expected to follow a typical growth trajectory. ADX (52.63) indicates a strong trend. +DI > -DI suggests strong bullish directional bias. RSI (80.33) is in the overbought zone, suggesting potential for price correction. MACD line (1.32) is below Signal line (1.33) (bearish crossover), confirming downward momentum. Current Weekly ATR is 0.34, indicating the average weekly price range.
2026-11-04
Bearish Scenario
from current -16.89%
Long-term bearish trend with significant headwinds from economic factors, industry disruption, or company-specific issues. Expect notable price depreciation. ADX (52.63) indicates a strong trend. +DI > -DI suggests strong bullish directional bias. RSI (80.33) is in the overbought zone, suggesting potential for price correction. MACD line (1.32) is below Signal line (1.33) (bearish crossover), confirming downward momentum. Current Weekly ATR is 0.34, indicating the average weekly price range.
Technical Analysis (VIGL)
Trend Identification
EMA
Exponential Moving Average
Current price (8.05) is between Short MA (8.05) and Long MA (6.86), or near one of them. This suggests consolidation or mixed signals. Short MA (8.05) is above Long MA (6.86), a bullish crossover ('Golden Cross' if it's a significant period). This indicates an upward trend. MAs (8.05, 6.86, 4.87) show mixed alignment, suggesting market indecision or range-bound activity. Market is in a choppy or sideways phase. Wait for a clearer trend to emerge before taking directional trades.
MACD
Moving Average Convergence Divergence
MACD line is below the Signal line (bearish crossover). This indicates downward momentum. Histogram (-0.0700) is negative and expanding, confirming bearish momentum. Both MACD and Signal lines are above the zero line, reinforcing bullish momentum (bullish territory). A bearish crossover above the zero line can indicate a reversal from a prior uptrend. Consider this as a potential early sell signal.
ADX
Average Directional Index
ADX (73.96) indicates a strong trend is present. +DI (46.34) is above -DI (10.99), suggesting a bullish directional bias. This combination points to a strong upward trend. Consider taking long positions, as the strong upward trend is confirmed.
Momentum Measurement
RSI (2026-11-04)
Relative Strength Index
RSI (78.76) is in the overbought zone. This suggests the asset may be due for a price correction or a trend reversal downwards. Consider profit-taking or short-selling opportunities cautiously.
OBV (2026-11-04)
On-Balance Volume
OBV (83780377.00) is flat, indicating indecision or a balanced market. Price is relatively stable. OBV movement will indicate hidden accumulation/distribution.
Stochastic (2026-11-04)
Stochastic Oscillator
Stochastics (%K: 33.33, %D: 25.00) are in the neutral zone (between 20 and 80). A bullish crossover (%K above %D) is observed, potentially signaling an upward trend reversal or continuation. Stronger signal if this occurs below 50.
CCI (2026-11-04)
Commodity Channel Index
CCI (-131.81) is below -100. This suggests a strong downward momentum and an oversold condition. Consider buying or looking for long entries cautiously. Confirm with price action; if price is making lower lows, momentum is strong. Look for rallies to enter short.
Volatility Measurement
ATR (2026-11-04)
Average True Range
Current ATR is 0.0400. ATR indicates average volatility. Market conditions are relatively stable.
Bollinger Bands (2026-11-04)
Volatility Bands
Current price (8.05) is within the Bollinger Bands (8.00 - 8.10). This suggests the price is trading within its typical volatility range. Price is at the Middle Band (8.05), which often acts as support/resistance. Watch for breakout. Bollinger Bands are very narrow. This indicates low volatility and could precede a significant price move (a 'squeeze'). Prepare for a breakout. Trade breakouts with confirmation from volume or other momentum indicators.
Risk Management & Potential Reversals (VIGL)
SAR (2026-11-04)
Parabolic Stop and Reverse
SAR points below price indicate bullish trend. Current SAR at 8.02 is 0.37% from price. Consider SAR as a potential stop-loss level to protect gains in an uptrend.
Stochastic (2026-11-04)
Neutral
Stochastic is in neutral territory (33.3). No clear overbought/oversold signal. Current crossover status: Bullish.
RSI (2026-11-04)
Reversal Perspective
Current RSI level suggests overbought conditions, indicating potential for a bearish reversal. No RSI divergence detected. Current RSI level doesn't suggest imminent reversal.
Bollinger Bands (2026-11-04)
Reversal Perspective
Bollinger Bands are narrowing, indicating low volatility and a potential 'squeeze'. This often precedes a significant price move.Price is in the middle of bands with normal bandwidth.
Holder List Top 20 (VIGL)
| Holder Name | Holder Type | Shares | Pct. Held | Date Reported |
|---|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | INSTITUTIONAL | 5836874 | 12.51% | 2025-03-31 |
| BVF Inc. | INSTITUTIONAL | 4013633 | 8.6% | 2025-03-31 |
| Siren, L.L.C. | INSTITUTIONAL | 1967064 | 4.21% | 2025-03-31 |
| 683 Capital Management LLC | INSTITUTIONAL | 1740000 | 3.73% | 2025-03-31 |
| Aberdeen Group plc | INSTITUTIONAL | 1724520 | 3.7% | 2025-03-31 |
| abrdn Life Sciences Investors | MUTUALFUND | 1659149 | 3.55% | 2025-03-31 |
| Sphera Funds Management Ltd. | INSTITUTIONAL | 1604429 | 3.44% | 2025-03-31 |
| Ensign Peak Advisors, Inc | INSTITUTIONAL | 1578116 | 3.38% | 2025-03-31 |
| Vanguard Group Inc | INSTITUTIONAL | 1048823 | 2.25% | 2025-03-31 |
| BLAIR WILLIAM & CO/IL | INSTITUTIONAL | 1033577 | 2.21% | 2025-03-31 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | MUTUALFUND | 710140 | 1.52% | 2025-03-31 |
| Pivotal bioVenture Partners Investment Advisor, LLC | INSTITUTIONAL | 560595 | 1.2% | 2025-03-31 |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | MUTUALFUND | 314330 | 0.67% | 2025-03-31 |
| GDL Fund | MUTUALFUND | 245000 | 0.52% | 2025-06-30 |
| BlackRock Health Sciences Term Trust | MUTUALFUND | 225247 | 0.48% | 2025-03-31 |
| Gabelli Investor Funds Inc-THE GABELLI ABC FUND | MUTUALFUND | 150000 | 0.32% | 2025-06-30 |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | MUTUALFUND | 115425 | 0.25% | 2025-04-30 |
| Bridgeway Funds, Inc.-Ultra-Small Company Market Fund | MUTUALFUND | 68664 | 0.15% | 2025-03-31 |
| Fidelity Concord Street Trust-Fidelity Total Market Index Fund | MUTUALFUND | 37613 | 0.08% | 2025-04-30 |
| iShares Trust-iShares Micro-Cap ETF | MUTUALFUND | 37489 | 0.08% | 2025-04-30 |